Predictors of Enrollment into a Familial Cancer Registry by Individuals at High Risk for BRCA1/2

Background: Registries of individuals at risk for hereditary cancer syndromes are an invaluable resource for cancer research, yet little is known about the predictors of enrollment in hereditary cancer registries. We sought to identify the factors that characterize individuals who enroll versus those who decline participation in a Familial Cancer Registry (FCR). We also sought to identify the factors associated with provision of a blood sample to the FCR. Methods: Participants (n = 549) had a 10% or greater prior probability of having a BRCA1/2 mutation or were members of a family with a known BRCA1/2 mutation. Results: Of 549 participants, 81.1% (n = 445) enrolled in the FCR and 18.9% (n = 104) declined. Independent significant predictors of FCR participation included: lower anxiety (odds ratio0.5 SD, 0.83; 95% confidence interval, 0.73-0.95) and being unaffected with breast or ovarian cancer (odds ratio, 0.52; 95% confidence interval, 0.39-0.67). Of the 445 FCR participants, 80.4% provided a blood sample whereas 19.6% declined, with blood sample provision predicted by being employed full time (odds ratio, 1.68; 95% confidence interval, 1.31-2.16). Conclusion: These findings have implications for the generalizability of results from research using hereditary cancer registry samples. Individuals who are affected with breast/ovarian cancer and have more anxiety are less likely to enroll in a hereditary cancer registry. Clinically, these results indicate that cancer registry enrollment strategies could benefit from the use of tailored approaches to increase the enrollment of individuals that are less likely to participate. (Cancer Epidemiol Biomarkers Prev 2007;16(12):2763–7)

[1]  D. Bowen,et al.  Predictors of Self-Referral into a Cancer Genetics Registry , 2007, Cancer Epidemiology Biomarkers & Prevention.

[2]  H. Lynch,et al.  Brain tumors in individuals with familial adenomatous polyposis , 2007, Cancer.

[3]  V. Venne,et al.  Colorectal Cancer Surveillance Behaviors Among Members of Typical and Attenuated FAP Families , 2007, The American Journal of Gastroenterology.

[4]  C. Isaacs,et al.  Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors , 2006, Breast Cancer Research and Treatment.

[5]  James S. Evans,et al.  Factors Associated with Enrollment in Cancer Genetics Research , 2006, Cancer Epidemiology Biomarkers & Prevention.

[6]  D. Bowen,et al.  Analysis of Co-Aggregation of Cancer Based on Registry Data , 2006, Public Health Genomics.

[7]  P. Salkovskis,et al.  Applying a cognitive behavioral model of health anxiety in a cancer genetics service. , 2006, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[8]  Shing M. Lee,et al.  Active recruitment increased enrollment in a hereditary cancer registry. , 2004, Journal of clinical epidemiology.

[9]  C. Skinner,et al.  Racial differences in enrolment in a cancer genetics registry. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[10]  P. McDonald,et al.  Minority recruitment in hereditary breast cancer research. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  Prakash Nadkarni,et al.  The Cancer Genetics Network: Recruitment Results and Pilot Studies , 2003, Public Health Genomics.

[12]  C. Hughes,et al.  Sociocultural influences on participation in genetic risk assessment and testing among African American women. , 2003, Patient education and counseling.

[13]  Susan L Neuhausen,et al.  Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. , 2002, The New England journal of medicine.

[14]  C. Isaacs,et al.  All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. , 2002, American journal of medical genetics.

[15]  W. Lawrence,et al.  Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  K. Heimdal,et al.  Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study , 2000, The Lancet.

[17]  O. Olopade,et al.  Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  D. Easton,et al.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. , 1993, American journal of human genetics.

[19]  L. Derogatis,et al.  The Brief Symptom Inventory: an introductory report , 1983, Psychological Medicine.

[20]  M. Horowitz,et al.  Impact of Event Scale: A Measure of Subjective Stress , 1979, Psychosomatic medicine.

[21]  D. Easton,et al.  Genetic Linkage Analysis in Familial Breast and Ovarian Cancer: Results from 214 Families , 2006 .

[22]  C. Isaacs,et al.  Breast and Ovarian Cancer Screening Practices in Healthy Women with a Strong Family History of Breast or Ovarian Cancer , 2004, Breast Cancer Research and Treatment.

[23]  N. Boyd,et al.  Characteristics associated with participation at various stages at the Ontario site of the cooperative family registry for breast cancer studies. , 2002, Annals of epidemiology.

[24]  K. Cox Informed consent and decision-making: patients' experiences of the process of recruitment to phases I and II anti-cancer drug trials. , 2002, Patient education and counseling.